Pursuant to the SEBI circular dated February 08, 2019, Aurobindo Pharma has informed that it has enclosed the Annual Secretarial Compliance Report for the year ended March 31, 2021 issued by the Practicing Company Secretary.
The above information is a part of company’s filings submitted to BSE.